PUNE, India, June 8, 2016 /PRNewswire/ --
The global clinical microbiology market is projected to reach $5.77 billion by 2021 from $3.35 billion in 2016, growing at a CAGR of 11.5%, dominated by North America and Europe that are expected to be the mature markets for clinical microbiology products in 2016.
Complete report on global clinical microbiology market spread across 176 pages, profiling 10 companies and supported with 74 tables and 62 figures is now available at http://www.reportsnreports.com/reports/323763-microbiology-testing-clinical-microbiology-market-by-product-instrument-analyzer-incubator-kit-microscope-molecular-diagnostics-clinical-application-periodontal-disease-respiratory-diseases-std-uti-by-industry-global-forecast-to-2019.html .
The global market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches. However, reimbursement concerns and unfavorable regulatory scenario are restraining the growth of the clinical microbiology market. Furthermore, improving healthcare infrastructure across the emerging markets and growing market demand for advanced molecular diagnostic products provide various opportunities in the clinical microbiology market. The operational barriers for diagnostic test usage and bundled sales by market giants across major markets are the major challenges limiting the growth of the global clinical microbiology market to a certain extent.
In this report, the global clinical microbiology market is segmented on the basis of product into instruments [laboratory instruments (incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, anaerobic culture systems, petridish fillers, blood culture systems, microbial culture systems, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, microscopes, and mass spectrometers)] and reagents (pathogen specific kits and general reagents).
Geographically, The North American clinical microbiology market is expected to hold the largest share of global clinical microbiology market in 2016. However, the Asia-Pacific clinical microbiology market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases.
From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the clinical microbiology market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.
Leading players in the clinical microbiology market include bioMerieux S.A. (France),Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.),Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland),Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.). Order a copy of Microbiology Testing / Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product (instruments, Analyzers, Consumables) - Global Forecasts to 2021 research report at http://www.reportsnreports.com/purchase.aspx?name=323763 .
On a related note, another research on Single-Cell Analysis Market Global Forecasts to 2021 says, the single-cell analysis market is expected to reach USD 3.35 billion by 2021 from USD 1.45 billion in 2016, at a CAGR of 18.2%. The consumables segment is expected to register the highest growth rate in the single-cell analysis market, byproduct, during the forecast period. The single-cell analysis market is dominated by North America, followed by Europe, Asia, and the RoW. Companies like Thermo Fisher Scientific Inc., Illumina, Inc., Becton, Dickinson and Company, QIAGEN N.V., Bio-Rad Laboratories, Inc., Agilent Technologies, Nanostring Technologies, Beckman Coulter, Fluidigm Corporation and Merck KGaA have been profiled in this 200 pages research report available at http://www.reportsnreports.com/reports/526898-single-cell-analysis-market-by-product-beads-microplate-reagents-flow-cytometer-microscope-spectrophotometer-cell-type-human-animal-technique-ngs-pcr-application-cancer-neurology-nipd-ivf-ctcs-end-user-global-forecasts-to-2021.html .
Explore more reports on the medical devices market at http://www.reportsnreports.com/market-research/medical-devices/.
ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
+ 1 888 391 5441
Connect With Us on:
Twitter: https: //twitter.com/marketsreports
G+ / Google Plus: https://plus.google.com/111656568937629536321/posts